Home > Glutathione > Sources

Sources

1. Sechi G, Deledda MG, Bua G, et al. Reduced intravenous glutathione in the treatment of early Parkinson’s disease. Prog Neuropsychopharmacol Biol Psychiatry 1996;20:1159-70.

2. Molloy J, Martin JF, Baskerville PA, et al. S-nitrosoglutathione reduces the rate of embolization in humans. Circulation 1998;98:1372-5.

3. Smyth JF, Bowman A, Perren T, et al. Glutathione reduces the toxicity and improves quality of life of woman diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomized trial. Ann Oncol 1997;8:569-73.

4. Cascinu S, Cordella L, Del Ferro E, et al. Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized, double-blind, placebo controlled trial. J Clin Oncol 1995;13:26-32.

5. Ceriello A, Giugliano D, Quatraro A, Lefebvre PJ. Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. Clin Sci 1991;81:739-42.

6. Lenzi A, Culasso F, Gandini L, et al. Placebo-controlled, double-blind, crossover trial of glutathione therapy in male infertility. Hum Reprod 1993;8:1657-62.

7. Staal FJ, Roederer M, Israelski DM, et al. Intracellular glutathione levels in T cell subsets decrease in HIV-infected individuals. AIDS Res Hum Retroviruses. 1992 Feb;8(2):305-11.

8. Yorbik O, Sayal A, Akay C, et al. Investigation of antioxidant enzymes in children with autistic disorder. Prostaglandins Leukot Essent Fatty Acids. 2002 Nov;67(5):341-3.

9. Morris PE, Bernard GR. Significance of glutathione in lung disease and implications for therapy. Am J Med Sci. 1994 Feb;307(2):119-27.

10. James LP, Mayeux PR, Hinson JA. Acetaminophen-induced hepatoxicity. Drug Metab Dispos. 2003 Dec;31(12):1499-506.

> back to Glutathione

Oral Liposomal
Glutathione Liquid
> Order Now